FMP
XETRA
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
42.55 EUR
0.25 (0.588%)
Valuation Date:
Apr 23, 2024 11:35 AM
Share Price on Valuation Date
$42.55
Stock Beta
0.832
Shares Outstanding
54846000